BioLife Solutions Inc
BLFS26.040USD
-0.250-0.95%
종가 11/11, 16:00（ET）시세는 15분 지연됩니다
1.25B시가총액
손실P/E TTM
자세한 내용은 BioLife Solutions Inc 회사
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
BioLife Solutions Inc 정보
종목 코드 BLFS
회사 이름BioLife Solutions Inc
상장일Nov 22, 1989
CEOMr. Roderick De Greef
직원 수159
유형Ordinary Share
회계 연도 종료Nov 22
주소Suite 310
도시BOTHELL
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호98021
전화14254011400
웹사이트https://www.biolifesolutions.com/
종목 코드 BLFS
상장일Nov 22, 1989
CEOMr. Roderick De Greef
BioLife Solutions Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
253.42K
-0.20%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.52K
-0.28%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
99.33K
-0.83%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
50.21K
-0.37%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-7.30%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
26.04K
-1.05%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
23.81K
-22.41%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
253.42K
-0.20%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.52K
-0.28%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
99.33K
-0.83%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
50.21K
-0.37%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
주식 보유 통계
마지막 업데이트: Fri, Oct 10
마지막 업데이트: Fri, Oct 10
주주
주주 유형
주주
주주
비율
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.55%
T. Rowe Price Investment Management, Inc.
8.82%
Invesco Advisers, Inc.
7.18%
The Vanguard Group, Inc.
6.15%
기타
54.93%
주주
주주
비율
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.55%
T. Rowe Price Investment Management, Inc.
8.82%
Invesco Advisers, Inc.
7.18%
The Vanguard Group, Inc.
6.15%
기타
54.93%
주주 유형
주주
비율
Investment Advisor
48.54%
Investment Advisor/Hedge Fund
33.79%
Hedge Fund
15.59%
Research Firm
2.52%
Individual Investor
2.10%
Pension Fund
1.57%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.08%
Venture Capital
0.05%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
405
50.24M
104.42%
-1.24M
2025Q2
411
47.71M
99.74%
-5.40M
2025Q1
430
51.12M
107.57%
-1.38M
2024Q4
407
48.89M
104.05%
-2.49M
2024Q3
404
46.98M
101.82%
-6.27M
2024Q2
385
48.82M
105.97%
-2.22M
2024Q1
377
46.95M
103.67%
-5.60M
2023Q4
397
47.58M
108.04%
-4.07M
2023Q3
399
45.29M
104.13%
-2.05M
2023Q2
401
44.87M
103.50%
-2.76M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Casdin Capital, LLC
6.71M
14%
-1.00M
-12.97%
Aug 15, 2025
BlackRock Institutional Trust Company, N.A.
5.08M
10.61%
+12.43K
+0.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.25M
8.86%
+2.90M
+215.04%
Jun 30, 2025
Invesco Advisers, Inc.
3.46M
7.22%
+126.62K
+3.80%
Jun 30, 2025
The Vanguard Group, Inc.
2.89M
6.03%
+93.13K
+3.33%
Jun 30, 2025
State Street Investment Management (US)
1.41M
2.94%
-24.84K
-1.73%
Jun 30, 2025
Fred Alger Management, LLC
1.25M
2.61%
-285.09K
-18.60%
Jun 30, 2025
MFS Investment Management
1.10M
2.3%
+337.42K
+44.13%
Jun 30, 2025
Rockefeller Capital Management
1.03M
2.14%
+62.16K
+6.45%
Jun 30, 2025
Columbia Wanger Asset Management, LLC
997.60K
2.08%
+116.26K
+13.19%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
Invesco S&P SmallCap Health Care ETF
0.63%
Invesco S&P SmallCap 600 Pure Growth ETF
0.55%
First Trust Multi-Manager Small Cap Opportunities ETF
0.48%
Zacks Small/Mid Cap ETF
0.38%
iShares Micro-Cap ETF
0.18%
SPDR S&P 600 Small Cap Growth ETF
0.13%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.12%
iShares ESG Select Screened S&P Small-Cap ETF
0.08%
iShares Core S&P Small-Cap ETF
0.07%
더 보기
Invesco S&P SmallCap Health Care ETF
비율0.63%
Invesco S&P SmallCap 600 Pure Growth ETF
비율0.55%
First Trust Multi-Manager Small Cap Opportunities ETF
비율0.48%
Zacks Small/Mid Cap ETF
비율0.38%
iShares Micro-Cap ETF
비율0.18%
SPDR S&P 600 Small Cap Growth ETF
비율0.13%
Vanguard S&P Small-Cap 600 Growth Index Fund
비율0.13%
iShares S&P Small-Cap 600 Growth ETF
비율0.12%
iShares ESG Select Screened S&P Small-Cap ETF
비율0.08%
iShares Core S&P Small-Cap ETF
비율0.07%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
